HBW
PFE icon

Hazlett, Burt & Watson’s Pfizer PFE Stock Holding History

Hazlett, Burt & Watson’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
10,050
-185
-2% -$4.84K 0.06% 243
2026
Q1 		$287K Buy
10,235
+4
+0% +$106 0.09% 209
2025
Q4 		$251K Sell
10,231
-183
-2% -$4.62K 0.08% 218
2025
Q3 		$265K Sell
10,414
-26
-0.2% -$642 0.09% 189
2025
Q2 		$251K Sell
10,440
-4,798
-31% -$112K 0.1% 176
2025
Q1 		$385K Sell
15,238
-166
-1% -$4.34K 0.17% 123
2024
Q4 		$410K Sell
15,404
-75
-0.5% -$2.03K 0.18% 118
2024
Q3 		$451K Sell
15,479
-789
-5% -$23K 0.21% 111
2024
Q2 		$456K Sell
16,268
-702
-4% -$19.3K 0.23% 93
2024
Q1 		$471K Sell
16,970
-2,037
-11% -$56.5K 0.28% 70
2023
Q4 		$548K Sell
19,007
-1,428
-7% -$43.2K 0.37% 55
2023
Q3 		$679K Buy
20,435
+724
+4% +$25.6K 0.51% 37
2023
Q2 		$722K Sell
19,711
-805
-4% -$31.3K 0.54% 30
2023
Q1 		$835K Buy
20,516
+304
+2% +$13.1K 0.68% 25
2022
Q4 		$1.04M Buy
20,212
+198
+1% +$9.49K 0.91% 21
2022
Q3 		$874K Buy
20,014
+1,409
+8% +$68.5K 0.85% 20
2022
Q2 		$977K Buy
18,605
+586
+3% +$29.9K 0.9% 20
2022
Q1 		$933K Buy
+18,019
New +$935K 0.74% 26

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hazlett, Burt & Watson's PFE Position: Q2 2026 in Review

Hazlett, Burt & Watson reduced its Pfizer (PFE) stake by 1.8% in Q2 2026, selling an estimated $4.84K and leaving 10,050 shares worth $242K. The position accounts for 0.06% of the portfolio, ranked #243.

Hazlett, Burt & Watson first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.04M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hazlett, Burt & Watson held 10,050 shares of Pfizer worth $242K as of Q2 2026.
  • Hazlett, Burt & Watson sold 185 Pfizer shares in Q2 2026, an estimated $4.84K.
  • Pfizer made up 0.06% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #243 holding.
  • Hazlett, Burt & Watson first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
  • Hazlett, Burt & Watson's Pfizer position peaked at $1.04M in Q4 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.